X射线造影剂
Search documents
博苑股份(301617) - 2026年1月16日投资者关系活动记录表
2026-01-19 00:10
Group 1: Company Overview - The company, Shandong Boyuan Pharmaceutical Chemical Co., Ltd., has an existing production capacity of 4,100 tons/year for iodide products, with a trial production project of 4,000 tons/year [2] - The main inorganic iodides include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide, while the organic iodides include trimethyl iodide and iodomethane [2] Group 2: Applications and Market Distribution - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, widely used in various product formulations [2] - The major applications of iodine include X-ray contrast agents, biocides, preservatives, pharmaceutical intermediates, LCD and LED screen polarizers, chemicals, organic compounds, and pigments [2] - According to SQM's 2024 annual report, the core application areas of iodine account for approximately 63% of global consumption, with significant production concentrated in Chile, Japan, and the USA, which together account for 88% of global sales [3] Group 3: Financial Performance - The company's net profit decreased year-on-year in the first nine months of 2025, primarily due to rising upstream material prices, which increased product cost pressures [3] Group 4: Production Processes and Innovations - The production of lithium iodide utilizes raw materials such as hydriodic acid, lithium carbonate, formic acid, activated carbon, and lithium hydroxide, involving processes like neutralization, vacuum concentration, cooling crystallization, filtration, and vacuum drying [3] - The company is conducting research and product development on the application of iodides in perovskite batteries, with related R&D projects currently in progress, but no products have been sold as of the report date [3]
博苑股份(301617) - 2025年12月30日投资者关系活动记录表
2025-12-30 09:12
Group 1: Company Overview - The company is Shandong Boyuan Pharmaceutical Chemical Co., Ltd., with stock code 301617 and abbreviation Boyuan Co., Ltd. [1] Group 2: Production Capacity - The current production capacity for iodide products is 4,100 tons/year, with trial production at 4,000 tons/year [2] - Inorganic iodides include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide; organic iodides include trimethyl iodide and iodomethane [2] Group 3: Applications and Market Distribution - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, with applications in X-ray contrast agents, disinfectants, pharmaceuticals, LCD and LED screens, and more [2] - The three core application areas—medical manufacturing and LCD panel manufacturing—account for approximately 63% of global iodine consumption [3] - Major iodine production is concentrated in Chile, Japan, and the USA, which together account for 88% of global sales [3] Group 4: Market Trends - The procurement price of iodine has shown an upward trend in recent years, with prices rising from 2020 to 2023 and stabilizing at relatively high levels without significant declines [3] Group 5: Financial Status - The company currently has a strong financial position, with healthy cash flow that adequately covers daily operations and project investments, indicating no financial pressure [3]
博苑股份:碘及碘衍生物广泛应用于各类产品配方中
Zheng Quan Ri Bao Zhi Sheng· 2025-08-25 08:08
Core Viewpoint - The announcement by Boyuan Co. highlights the significance of iodine and its derivatives as essential raw materials across various sectors, including healthcare, agriculture, and industry, with a focus on their applications in key products [1] Industry Overview - Iodine is widely used in various formulations as a key component or catalyst, with applications in X-ray contrast agents, disinfectants, pharmaceutical intermediates, LCD and LED screen polarizers, chemicals, organic compounds, and pigments [1] - Iodine is added to table salt in the form of potassium iodate or potassium iodide to prevent iodine deficiency [1] Market Structure - According to SQM's 2024 report, the downstream application structure of iodine is dominated by three core sectors: X-ray contrast agents, pharmaceutical manufacturing, and liquid crystal panel manufacturing, which together account for approximately 63% of global consumption [1] - The global iodine industry exhibits a distinct regional distribution, with major production concentrated in Chile, Japan, and the United States, which collectively account for 88% of global sales [1] - Five companies in Chile account for about 60% of global iodine sales, with SQM alone representing approximately 37% of this total; eight Japanese producers contribute around 23%, while U.S. producers account for nearly 5% [1] - Additional production exists in Russia, Turkmenistan, Azerbaijan, Indonesia, and China, albeit in smaller quantities [1]